T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 11/30/2016
Domestic Stock 59.2%
Domestic Bond 23.1%
Cash 8.3%
Foreign Bonds 4.2%
Foreign Stock 3.7%
Convertibles 1.5%
Preferreds 0.8%
Options -0.6%
Volatility and Other Measures
as of 11/30/2016
Beta 0.62
0.91
Standard Deviation 6.94
Price/Earnings Ratio (Domestic) 18.9
Earnings Growth Rate (Domestic) 11.1
Turnover Rate N/A
Median Market
Capitalization
$50,138.9 Million
Sector Diversification
as of 11/30/2016
% of Total Net Assets
Health Care 17.2%
Information Technology 10.8%
Consumer Staples 9.1%
Financials 8.5%
Consumer Discretionary 8.2%
Industrials & Business Services 4.2%
Utilities 3.4%
Energy 1.2%
Real Estate 0.9%
Materials 0.5%
Telecommunication Services 0.4%
10 Largest Holdings
Represents 24.34 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
Alphabet
Bank of New York Mellon
Becton, Dickinson & Company
Danaher
Fiserv
Marsh & McLennan
Microsoft
PG&E
Thermo Fisher Scientific
As of 11/30/2016 the Capital Appreciation Fund had a total of 297 holdings.
See Glossary for additional details on all data elements.